Hot Stocks Moves: OXiGENE, Inc. (NASDAQ:OXGN), Novartis AG (NYSE:NVS), Dendreon Corp. (NASDAQ:DNDN)

OXiGENE, Inc. (NASDAQ:OXGN) Trend Analysis released that first presentation at a scientific conference of the optimistic results from the Phase 2 GOG 186I study of fosbretabulin combined with bevacizumab in recurrent ovarian, tubal and peritoneal carcinoma. OXiGENE, Inc. (NASDAQ:OXGN) begun last trade with a price of $2.11 and throughout the trading session climbed at a high of $2.11. The day-trade ended with -8.33% to $1.98. The stock is going forward to its 52 week low with 13.14% and lagging behind from its 52 week high price with -63.33%. OXGN last month stock price volatility remained 8.08%.Novartis AG (NYSE:NVS) Trend Analysis released that its four oral presentations and four posters for AIN457 will be presented at the American College of Rheumatology Congress, 14-19 November, in Boston, Massachusetts, USA. The secukinumab abstracts include data from two pivotal Phase III studies (FUTURE 1 and FUTURE 2) in psoriatic arthritis (PsA) patients and two pivotal Phase III studies in patients with ankylosing spondylitis. All studies met primary endpoints. Novartis AG (NYSE:NVS) has the market capitalization of 224.0 Billion. Shares of firm surged 0.95% to close at $92.63 with the total traded volume of 822297. The firm has current ratio of 1.40 for the most recent quarter.Dendreon Corp. (NASDAQ:DNDN) Trend Analysis released that it has reached contracts on the terms of a financial restructuring with certain holders of the Company's 2.875% Convertible Senior Notes due 2016 representing approximately 84% of the $620 million aggregate principal amount of the 2016 Notes. Dendreon Corp. (NASDAQ:DNDN) stock price closed at $0.18 with the total traded volume of 63.99 Million shares. Its price to sales ratio ended at 0.10. Its market capitalization is 28.0 Million. The stock owned by the Financial Institutions was 35.90% while by insiders was 1.70%.